- Home
- ALLT vs CADL Comparison
ALLT vs CADL Comparison
Compare ALLT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- CADL
- Stock Information
- Founded
- ALLT 1996
- CADL 1999
- Country
- ALLT Israel
- CADL United States
- Employees
- ALLT N/A
- CADL N/A
- Industry
- ALLT Telecommunications Equipment
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- CADL Health Care
- Exchange
- ALLT Nasdaq
- CADL Nasdaq
- Market Cap
- ALLT 229.8M
- CADL 234.8M
- IPO Year
- ALLT 2006
- CADL 2021
- Fundamental
- Price
- ALLT $8.34
- CADL $5.52
- Analyst Decision
- ALLT Buy
- CADL Strong Buy
- Analyst Count
- ALLT 1
- CADL 4
- Target Price
- ALLT $13.00
- CADL $21.00
- AVG Volume (30 Days)
- ALLT 321.2K
- CADL 885.1K
- Earning Date
- ALLT 05-12-2025
- CADL 05-13-2025
- Dividend Yield
- ALLT N/A
- CADL N/A
- EPS Growth
- ALLT N/A
- CADL N/A
- EPS
- ALLT N/A
- CADL N/A
- Revenue
- ALLT $93,455,000.00
- CADL N/A
- Revenue This Year
- ALLT $6.43
- CADL N/A
- Revenue Next Year
- ALLT $5.83
- CADL N/A
- P/E Ratio
- ALLT N/A
- CADL N/A
- Revenue Growth
- ALLT N/A
- CADL N/A
- 52 Week Low
- ALLT $2.02
- CADL $3.79
- 52 Week High
- ALLT $9.44
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ALLT 69.53
- CADL 52.31
- Support Level
- ALLT $5.61
- CADL $4.34
- Resistance Level
- ALLT $8.70
- CADL $5.59
- Average True Range (ATR)
- ALLT 0.48
- CADL 0.34
- MACD
- ALLT 0.27
- CADL 0.15
- Stochastic Oscillator
- ALLT 78.76
- CADL 82.37
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.